Fonte: American Journal of Cardiology. Unidade: HU
Assuntos: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, DOENÇAS CARDIOVASCULARES, TROMBOEMBOLISMO, FATORES DE RISCO, CÁLCIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ARPS, Kelly et al. Usefulness of coronary artery calcium to identify adults of sufficiently high risk for atherothrombotic cardiovascular events to consider low-dose rivaroxaban thromboprophylaxis (from MESA). American Journal of Cardiology, v. 124, n. 8, p. 1198-1206, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.amjcard.2019.07.016. Acesso em: 04 nov. 2024.APA
Arps, K., Al Rifai, M., Blaha, M. J., Michos, E. D., Nasir, K., Yeboah, J., et al. (2019). Usefulness of coronary artery calcium to identify adults of sufficiently high risk for atherothrombotic cardiovascular events to consider low-dose rivaroxaban thromboprophylaxis (from MESA). American Journal of Cardiology, 124( 8), 1198-1206. doi:10.1016/j.amjcard.2019.07.016NLM
Arps K, Al Rifai M, Blaha MJ, Michos ED, Nasir K, Yeboah J, Budoff MJ, Blumenthal RS, Bittencourt MS, McEvoy JW. Usefulness of coronary artery calcium to identify adults of sufficiently high risk for atherothrombotic cardiovascular events to consider low-dose rivaroxaban thromboprophylaxis (from MESA) [Internet]. American Journal of Cardiology. 2019 ; 124( 8): 1198-1206.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.amjcard.2019.07.016Vancouver
Arps K, Al Rifai M, Blaha MJ, Michos ED, Nasir K, Yeboah J, Budoff MJ, Blumenthal RS, Bittencourt MS, McEvoy JW. Usefulness of coronary artery calcium to identify adults of sufficiently high risk for atherothrombotic cardiovascular events to consider low-dose rivaroxaban thromboprophylaxis (from MESA) [Internet]. American Journal of Cardiology. 2019 ; 124( 8): 1198-1206.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.amjcard.2019.07.016
